Double redirects
Jump to navigation
Jump to search
This page lists pages that redirect to other redirect pages.
Each row contains links to the first and second redirect, as well as the target of the second redirect, which is usually the "real" target page to which the first redirect should point.
Crossed out entries have been solved.
Showing below up to 14 results in range #1 to #14.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- Coagulopathies → Acquired coagulopathy → Acquired hemophilia A
- ARN-509 → Apalutamide (ARN-509) → Apalutamide (Erleada)
- Autoimmune hemolytic anemia (AIHA) → Autoimmune hemolytic anemia → Warm autoimmune hemolytic anemia
- AIHA → Autoimmune hemolytic anemia → Warm autoimmune hemolytic anemia
- CPX-351 → Cytarabine and daunorubicin (Vyxeos) → Cytarabine and daunorubicin liposomal (Vyxeos)
- Cytomegalovirus Human Immunoglobulin (CMV Immunoglobulin-VF) → Cytomegalovirus (CMV) Human Immunoglobulin (Cytogam) → Cytomegalovirus Immune Globulin (Cytogam)
- IPI-145 → Duvelisib (IPI-145) → Duvelisib (Copiktra)
- AG-120 → Ivosidenib (AG-120) → Ivosidenib (Tibsovo)
- XmAb5574 (MOR00208) → MOR208 → Tafasitamab (Monjuvi)
- Momelotinib → Momelotinib (CYT-387) → Momelotinib (Ojjaara)
- Pacritinib → Pacritinib (SB1518) → Pacritinib (Vonjo)
- Uracil-tegafur (UFT) → Tegafur-uracil (UFT) → Tegafur and uracil (UFT)
- Category:EGFR medications → Category:Solid malignant neoplasm, EGFR-mutated medications → Category:Malignant solid neoplasm, EGFR-mutated medications
- Category:EGFR regimens → Category:Solid malignant neoplasm, EGFR-mutated regimens → Category:Malignant solid neoplasm, EGFR-mutated regimens